Agendia

Agendia is a biotech company in Irvine, United States, founded in 2003. It has raised $123.0M across 4 rounds, most recently a $35.0M Growth Equity in July 2018.

Headquarters
Irvine
Founded
2003
Total Funding
$123.0M
Last Round
$35.0M Growth EquityJul 2018
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.

About

Agendia is a molecular diagnostics company focused solely on breast cancer, incorporated in the Netherlands in 2003, with its wholly-owned subsidiary Agendia, Inc. headquartered at 22 Morgan, Irvine, California. The company focuses on the discovery, development, and commercialization of innovative personalized cancer diagnostic products, using genomic testing to generate clinical data about the unique biology of breast cancer. Its customers include reference laboratories, hospitals, academic institutions, and distributors that complete Agendia's Partner Reference Laboratory certification process to access products such as its NGS Kit.

Summary

It has raised $123.0M in total across 4 rounds, most recently a $35.0M Growth Equity round in Jul 2018. Investors include Athyrium Capital Management and Korys.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityJul 2018
$35.0M

Sign up to see all 4 events

Funding: Series E through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Agendia on Indexed.vc
<a href="https://indexed.vc/companies/agendia"><img src="https://indexed.vc/api/badge/company/agendia" alt="Agendia on Indexed.vc" width="260" height="76" /></a>